Internal Medicine, Hematology & Oncology · Rome, GA
NPI
1588725188
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
255 W 5th St SW
Rome, GA, 30165
Phone (706) 295-3855
Groups this clinician bills Medicare through
Medicare paid, 2024
$3.0M
134,565 services
Medicare patients, 2024
404
Average age 75
Drug cost, 2024
$7.6M
2,571 prescriptions
Company payments, 2025
$117
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Dilawar Khan was code J9271 (injection, pembrolizumab, 1 mg), 24,600 times for 23 patients. In total Dilawar Khan billed 134,565 services in 161 codes, and Medicare paid $3.0M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-04-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9271 Injection, pembrolizumab, 1 mg | Office | 24,600 | 23 | $40.82 | $1.0M |
| J0897 Injection, denosumab, 1 mg | Office | 7,140 | 27 | $20.32 | $145K |
| J0185 Injection, aprepitant, 1 mg | Office | 6,370 | 22 | $1.35 | $8,590 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,812 | 49 | $0.76 | $1,377 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,744 | 44 | $0.09 | $154 |
| 36415 Venipuncture Blood Collection | Office | 1,547 | 281 | $8.48 | $13K |
| 85025 Blood Count | Office | 1,453 | 266 | $7.40 | $11K |
| 80053 Clinical Chemistry | Office | 1,069 | 263 | $10.17 | $11K |
| 99214 Office E&M - Established | Office | 571 | 222 | $83.84 | $48K |
| J9045 Injection, carboplatin, 50 mg | Office | 422 | 18 | $2.81 | $1,184 |
| 96413 Chemotherapy Administration | Office | 394 | 96 | $84.88 | $33K |
| 82784 Immunoassay | Office | 312 | 36 | $8.94 | $2,789 |
| 96372 Injection Administration | Office | 265 | 55 | $9.90 | $2,624 |
| 96375 Injection Administration | Office | 263 | 53 | $10.97 | $2,886 |
| 96367 Intravenous Infusion, Hydration | Office | 228 | 52 | $19.50 | $4,447 |
By year: 2022 $2.8M for 188,487 services; 2023 $3.2M for 181,220 services; 2024 $3.0M for 134,565 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,547 | 281 | $8.48 | $13K |
| 85025 Blood Count | 1,453 | 266 | $7.40 | $11K |
| 80053 Clinical Chemistry | 1,069 | 263 | $10.17 | $11K |
| 82784 Immunoassay | 312 | 36 | $8.94 | $2,789 |
| 84443 Clinical Chemistry | 131 | 37 | $14.85 | $1,945 |
| 84153 Clinical Chemistry | 113 | 26 | $16.93 | $1,913 |
| 82607 Clinical Chemistry | 89 | 70 | $14.34 | $1,276 |
| 82728 Clinical Chemistry | 87 | 56 | $12.90 | $1,122 |
| 83540 Clinical Chemistry | 86 | 57 | $6.10 | $525 |
| 83550 Clinical Chemistry | 85 | 57 | $8.22 | $699 |
Medicare prescription drug claims, 2024
In 2024, the drug Dilawar Khan prescribed most often to Medicare patients was Ondansetron Hcl, with 233 prescriptions and refills. In total Dilawar Khan wrote 2,571 Medicare prescriptions that cost $7.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ondansetron Hcl Generic | 233 | 236 | 103 | $5,501 |
| Anastrozole Generic | 230 | 564 | 59 | $3,560 |
| Prochlorperazine Maleate Generic | 116 | 119 | 56 | $1,812 |
| Dexamethasone Generic | 101 | 106 | 44 | $2,040 |
| Revlimid Lenalidomide | 88 | 88 | Under 11 | $1.5M |
| Mirtazapine Generic | 88 | 132 | 34 | $1,117 |
| Acyclovir Generic | 70 | 110 | 13 | $862 |
| Lenalidomide Generic | 69 | 69 | Under 11 | $990K |
| Prednisone Generic | 69 | 83 | 22 | $442 |
| Xtandi Enzalutamide | 66 | 66 | Under 11 | $753K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 64 | 64 | 37 | $1,057 |
| Sertraline Hcl Generic | 56 | 84 | 14 | $196 |
| Gabapentin Generic | 53 | 55 | 14 | $848 |
| Exemestane Generic | 52 | 72 | Under 11 | $3,130 |
| Hydroxyurea Generic | 45 | 89 | Under 11 | $1,666 |
Brand drugs: 505 claims; generic drugs: 2,066 claims; opioid claims: 138.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Dilawar Khan $117 ($117 in general payments such as food, travel and fees) from 2 companies. The largest payer was Novo Nordisk Inc with $94.57.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.